Search Results

CME CME Group Inc. - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
CME Stock | Fundamental Analysis & Investment Insights
NASDAQ Financial Services Financial Data & Stock Exchanges
Current Price Live
$285.04
Analyst Target
$285.12
0.0% Downside
52W High
$290.79
52W Low
$224.62

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Nov 16, 2025
Market cap
$102.78B
P/E
27.62
ROE
13.3%
Profit margin
58.9%
Debt/Equity
0.13
Dividend yield
1.75%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
75%
Analysis Accuracy
CME Group trades near fair value with strong profitability and a dominant market position in financial derivatives, supported by a 58.95% profit margin and 63.39% operating margin—both well above sector averages. However, near-term revenue contraction (-3.0% YoY) and stagnant earnings growth (0.0% YoY) raise concerns about cyclical headwinds, while the P/E of 27.6x is above the sector average of 21.8x, limiting upside. Price momentum remains solid with a 1Y return of +33.3%, but insider selling and a 103.7% payout ratio signal caution. Analysts are unanimous in a 'hold' rating, aligning with our neutral stance given mixed fundamentals and valuation.

Key Strengths

Exceptional profitability with 58.95% net margin and 63.39% operating margin, significantly above sector average of 24.08%
Dominant market position in futures and options with $102.78B market cap, the largest in its peer group
Low leverage with Debt/Equity of 0.13, well below sector average of 0.82 and peers like MCO (1.81)
Consistent earnings beat history: 23 of last 25 quarters met or exceeded estimates, with only two negative surprises in five years
Attractive dividend yield of 1.75%, above S&P 500 average, despite payout concerns

Key Risks

Revenue declining YoY (-3.0%) amid lower trading volumes, suggesting cyclical or structural demand weakness
Elevated valuation: P/E of 27.6x vs sector average of 21.8x and peer ICE at 27.7x, offering limited margin of safety
Payout ratio of 103.68% exceeds earnings, indicating dividend is not fully covered by net income and may not be sustainable long-term
Insider selling trend: $3.79M in net sales over last 6 months, including CTO selling 11,896 shares, signaling lack of confidence
Weak liquidity profile: Quick ratio of 0.02 indicates near-zero liquid assets relative to current liabilities, a red flag despite low debt
AI Fair Value Estimate
Based on comprehensive analysis
$285.0
-0.0% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
62
Strong
Value
55
Future
50
Past
85
Health
70
Dividend
50
AI Verdict
CME Group is fairly valued with best-in-class profitability and a fortress balance sheet, but near-term growth stagnation, stretched valuation relative to sector, and insider selling constrain upside; it trades in line with peers like ICE despite weaker growth, warranting a neutral stance.
Key drivers: Superior margin profile and ROE stability, Cyclical revenue pressure and flat earnings growth, Valuation premium to sector with limited growth to justify it
Confidence
75%
Value
55/100

CME’s valuation is premium to the Financial Services sector average P/E of 21.8x and higher than profitable peers like MMC (21.92), despite weaker revenue growth than most, making it appear relatively expensive for its growth profile.

Positives
  • P/E of 27.6x is in line with close peer ICE (27.7x), suggesting market is pricing in stability
  • Price/Sales of 16.1x reflects pricing power in exchange business model
Watchpoints
  • P/E of 27.6x is 26.7% above sector average of 21.8x, with no growth premium to justify it
  • Lack of EV/EBITDA and forward cash flow data limits deep value assessment
Future
50/100

With revenue and earnings flat to down and 6M price return of only +4.1%, future momentum is muted despite strong 1Y and 3Y returns, suggesting recent performance may be priced in without clear catalysts ahead.

Positives
  • Exchange business model benefits from long-term trends in derivatives adoption and risk management demand
  • Potential for volume recovery in rates and equity index futures if volatility increases in 2026
Watchpoints
  • Revenue down 3.0% YoY and Q/Q EPS down 9.5%, indicating weakening near-term momentum
  • No visibility on growth reacceleration given flat earnings and lack of Q/Q growth data
Past
85/100

CME has delivered exceptional earnings predictability and strong long-term price performance (5Y +107%, 3Y +88.5%), underpinned by consistent margin strength, though ROA suggests capital intensity or low asset turnover.

Positives
  • Remarkable earnings consistency: 23 of last 25 quarters beat or met estimates, with only two misses over five years
  • Profit margins and ROE have remained stable, demonstrating pricing power and cost discipline
Watchpoints
  • Gross margin reported at 100% is likely a data artifact (common in service firms with no COGS), overstating operational efficiency
  • ROA of 1.60% is very low, indicating inefficient asset utilization despite high ROE
Health
70/100

While CME’s leverage is well below sector average of 0.82 and peers like MCO (1.81), its near-zero quick ratio is a structural red flag unless explained by regulatory cash segregation, which is typical for exchanges but still warrants scrutiny.

Positives
  • Very low Debt/Equity of 0.13, providing significant financial flexibility and resilience
  • No immediate refinancing risk due to conservative leverage
Watchpoints
  • Current ratio of 1.02 and quick ratio of 0.02 indicate severe liquidity risk—likely due to customer cash segregation in exchange operations
  • Missing total cash and debt figures limit full solvency assessment
Dividend
50/100

The dividend offers income appeal but is not conservatively funded, with a payout ratio above 100%, making it riskier than peers with lower yields but stronger coverage like MMC or ICE.

Positives
  • Dividend yield of 1.75% is attractive in current rate environment and above S&P 500 average (~1.5%)
  • Company maintains consistent payout with $5.00 annual rate, signaling policy discipline
Watchpoints
  • Payout ratio of 103.68% exceeds 100%, meaning dividends are being paid from sources other than net income, raising sustainability concerns
  • No data on dividend growth history or 5-year average yield limits visibility into commitment

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$285.04
Analyst Target
$285.12
Upside/Downside
0.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CME and closest competitors.

Updated 2025-11-14
Company 5Y 3Y 1Y 6M 1M 1W
CME
CME Group Inc.
Primary
+107.0% +88.5% +33.3% +4.1% +6.3% +3.1%
BN
Brookfield Corporation
Peer
+139.4% +96.9% +19.5% +4.9% +1.2% -0.4%
BMO
Bank of Montreal
Peer
+120.0% +57.5% +42.1% +21.6% +5.5% +0.9%
HOOD
Robinhood Markets, Inc.
Peer
+212.3% +1042.2% +136.0% -0.9% -6.1% -5.7%
BNS
The Bank of Nova Scotia
Peer
+76.6% +68.7% +49.2% +32.2% +1.1% +1.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
27.62
Forward P/E
27.49
PEG Ratio
N/A
P/B Ratio
3.64
P/S Ratio
16.1
EV/Revenue
16.29
EV/EBITDA
23.14
Market Cap
$102.78B

Profitability

Profit margins and return metrics

Profit Margin 58.95%
Operating Margin 63.39%
Gross Margin 100.0%
ROE 13.35%
ROA 1.6%

Growth

Revenue and earnings growth rates

Revenue Growth -3.0%
Earnings Growth -0.4%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -0.5%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.13
Low debt
Current Ratio
1.02
Good
Quick Ratio
0.02
Poor
Cash/Share
$7.13

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-11
$N/A
2025-10-22
$2.68
+2.0% surprise
2025-07-23
$2.96
+0.6% surprise
2025-04-23
$2.8
-0.3% surprise

Financial Services Sector Comparison

Comparing CME against 208 companies in the Financial Services sector (5 bullish, 111 neutral, 92 bearish)
P/E Ratio
27.62
This Stock
vs
30.37
Sector Avg
-9.0% (Discount)
Return on Equity (ROE)
13.35%
This Stock
vs
-7.62%
Sector Avg
-275.1% (Below Avg)
Profit Margin
58.95%
This Stock
vs
82.75%
Sector Avg
-28.8% (Weaker)
Debt to Equity
0.13
This Stock
vs
1.48
Sector Avg
-90.9% (Less Debt)
Revenue Growth
-3.0%
This Stock
vs
28.35%
Sector Avg
-110.6% (Slower)
Current Ratio
1.02
This Stock
vs
3.81
Sector Avg
-73.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
CME
CME Group Inc.
NEUTRAL $102.78B 27.62 13.3% 58.9% $285.04
BN
Brookfield Corporation
NEUTRAL $106.0B 131.03 1.0% 1.3% $47.17
BMO
Bank of Montreal
NEUTRAL $98.97B 16.77 10.1% 26.7% $137.69
HOOD
Robinhood Markets, Inc.
NEUTRAL $97.78B 45.5 27.8% 52.2% $108.74
BNS
The Bank of Nova Scotia
NEUTRAL $93.29B 18.17 9.0% 24.6% $74.87

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-11-07 PIELL HILDA HARRIS Officer Gift 973 -
2025-11-03 FORD HAROLD EUGENE JR Director Sale 1,000 $263,530
2025-09-18 MARCUS JONATHAN L General Counsel Sale 392 $102,704
2025-09-16 MCCOURT TIMOTHY FRANCIS Officer Sale 379 $98,476
2025-09-16 MARCUS JONATHAN L General Counsel Sale 376 $97,369
2025-09-15 DUFFY TERRENCE A Chief Executive Officer Stock Award 23,180 $5,999,679
2025-09-15 SPRAGUE SUZANNE Officer Stock Award 3,044 $787,879
2025-09-15 FITZPATRICK LYNNE President Stock Award 4,348 $1,125,393
2025-09-15 MCCOURT TIMOTHY FRANCIS Officer Stock Award 2,752 $712,300
2025-09-15 MARCUS JONATHAN L General Counsel Stock Award 2,464 $637,757
2025-09-15 DENNIS MICHAEL G Officer Stock Award 2,608 $675,029
2025-09-15 TOBIN JACK J Officer Stock Award 1,546 $400,151
2025-09-15 WINKLER JULIE Officer Stock Award 3,044 $787,879
2025-09-15 CUTINHO SUNIL KIRAN Chief Technology Officer Stock Award 3,044 $787,879
2025-09-15 SAMMANN DEREK LOUIS Officer Stock Award 3,044 $787,879
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
17 analysts
Piper Sandler
2025-11-13
Maintains
Overweight Overweight
UBS
2025-10-23
Maintains
Neutral Neutral
Morgan Stanley
2025-10-23
Maintains
Overweight Overweight
Deutsche Bank
2025-10-23
up
Hold Buy
Raymond James
2025-10-13
Maintains
Outperform Outperform
Barclays
2025-10-08
Maintains
Equal-Weight Equal-Weight
Morgan Stanley
2025-10-01
Maintains
Overweight Overweight
JP Morgan
2025-09-25
Maintains
Underweight Underweight
Citigroup
2025-09-25
up
Neutral Buy
UBS
2025-09-08
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning CME from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile